{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-006927","form_type":"8-K","ticker":"HRGN","cik":"0001563665","company_name":"Harvard Apparatus Regenerative Technology, Inc.","filed_at":"2023-03-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.594100+00:00","generated_at":"2026-06-18T09:42:01.225296+00:00","sec_items":["1.01","8.01","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Biostage appoints Jerry He as Chairman and CEO; David Green remains on Board","bullets":["Jerry He appointed Chairman and CEO effective March 1, 2023, replacing David Green.","David Green to remain on Board and support transition.","He previously served as EVP of Bright Scholar Education and CEO of Noah Education.","Biostage is a clinical-stage biotech developing regenerative medicine for esophageal cancer.","Company plans to begin FDA-approved clinical trial for esophageal cancer."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-006927","json":"https://secwatch.observer/filing/0001493152-23-006927.json","markdown":"https://secwatch.observer/filing/0001493152-23-006927.md","text":"https://secwatch.observer/filing/0001493152-23-006927.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1563665/000149315223006927/0001493152-23-006927-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1563665/000149315223006927/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T09:42:01.225296+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1544182ef6","claim":"David Green resigned as Chairman and Chief Executive Officer at Harvard Apparatus Regenerative Technology, Inc..","evidence_excerpt":"in replacement of David Green in such roles.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1563665/000149315223006927/0001493152-23-006927-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chairman and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"22d335a0cf","claim":"Junli (Jerry) He was appointed as Chairman and Chief Executive Officer at Harvard Apparatus Regenerative Technology, Inc..","evidence_excerpt":"Junli (Jerry) He, was appointed Chairman and Chief Executive Officer of the Company, in replacement of David Green in such roles.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1563665/000149315223006927/0001493152-23-006927-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chairman and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}